Skip to main content
ILSUNG IS CO., LTD. logo

ILSUNG IS CO., LTD. — Investor Relations & Filings

Ticker · 003120 ISIN · KR7003120003 KO Manufacturing
Filings indexed 212 across all filing types
Latest filing 2023-02-06 Major Shareholding Noti…
Country KR South Korea
Listing KO 003120

About ILSUNG IS CO., LTD.

https://www.ilsung.com/

ILSUNG IS CO., LTD. is a pharmaceutical company specializing in the development and manufacturing of therapeutic products. The company's core portfolio is focused on antibiotics, cardiovascular agents, anesthetics, and contrast media. It is actively expanding its research and development into new therapeutic areas, including treatments for gastrointestinal (GI), central nervous system (CNS), and other cardiovascular (CV) conditions.

Recent filings

Filing Released Lang Actions
[기재정정]최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed with the Korean regulatory authority. It details specific changes in share ownership by major shareholders and directors, including the name of the individual (Yoon Seok-geun), the number of shares changed, and the reason for the change. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant changes in ownership levels by major stakeholders.
2023-02-06 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from Il-Sung Pharmaceuticals regarding a significant change in revenue or profit structure (30% or more). This is a standard financial disclosure required by the Korea Exchange (KRX) when a company's financial performance deviates significantly from the previous period. It provides key financial highlights (revenue, operating profit, net income) and explains the reasons for the change. It is not a full annual report (10-K) or an interim report (IR), but rather an initial earnings-related disclosure, which falls under the Earnings Release (ER) category. FY 2022
2023-02-03 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Il-Sung Pharmaceuticals. It details specific changes in share ownership by major shareholders and executives, including names, dates of change, and the number of shares involved. This falls under the category of 'Major Shareholding Notification' (MRQ), which tracks changes in significant share ownership levels.
2023-02-03 Korean
[기재정정]유형자산취득결정
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Il-Sung Pharmaceutical regarding an amendment to a previous disclosure about the acquisition of tangible assets (land and buildings). It details the change in the expected completion date of construction. Since it is a specific regulatory disclosure regarding corporate asset acquisition and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2023-01-26 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Ilsung Pharmaceuticals (일성신약) for the third quarter of 2022. It contains detailed financial information, business operations, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
[기재정정]유형자산취득결정
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Il-Sung Pharmaceutical regarding an amendment (correction) to a previous disclosure about the acquisition of tangible assets (real estate). It details the change in the expected payment date for the balance of the acquisition. Since this is a specific regulatory disclosure regarding corporate asset acquisition and does not fit into the other specialized categories like M&A or capital changes, it is classified as a general regulatory filing.
2022-09-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.